Abstract Objective To investigate the association between rs1799864 single nucleotide polymorphism (SNP) of the C-C chemokine receptor 2 (CCR2) gene and susceptibility of hemophagocytic lymphohistiocytosis (HLH) in children. Methods The clinical and laboratory data of 86 children diagnosed with HLH between January 2007 and December 2013 were retrospectively reviewed. The CCR2 gene rs1799864 was genotyped by SNaPshot technique in 86 HLH children and 128 healthy controls. The genotypic and allelic frequencies in the two groups were comparatively analyzed. Results No significant difference either in genotypic or allelic frequencies of rs1799864 polymorphism of the CCR2 gene was observed between HLH patients and controls (P>0.05), but there were significant differences in the age of onset and the periods of temperature and platelet returning to normal after treatment (P<0.05). Conclusions There is no association between CCR2 gene rs1799864 polymorphism and the risk for HLH in children. However, the genotypic differences of this polymorphism might be associated with clinical characteristics and prognosis of HLH.
About author:: 10.7499/j.issn.1008-8830.2015.02.011
Cite this article:
OU Dan-Yan,LUO Jian-Ming,TANG Li-Juan. Association of CCR2 gene rs1799864 polymorphism with hemophagocytic lymphohistiocytosis in children[J]. CJCP, 2015, 17(2): 164-167.
OU Dan-Yan,LUO Jian-Ming,TANG Li-Juan. Association of CCR2 gene rs1799864 polymorphism with hemophagocytic lymphohistiocytosis in children[J]. CJCP, 2015, 17(2): 164-167.
Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts[J]. Curr Opin Pediatr, 2012, 24(1): 9-15.
[2]
Henter JI, Horne AC, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
[3]
Jordan MB, Hildeman D, Kappler J, et a1. An animal model of hemophagoeytic lymphohistiocytosis(HLH): CD8+ T cells and interferon gamma are essential for the disorder[J]. Blood, 2004, 104(3): 735-743.
[4]
Sumegi J, Barnes MG, Nestheide SV, et al. Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis[J]. Blood, 2011, 117(15): e151-e160.
Clark MR, Massenburg D, Zhang M, et al. Molecular mechanisms of B cell antigen receptor traffificking[J]. Ann N Y Acad Sci, 2003, 987: 26-37.
[11]
Rittig K, Peter A, Baltz KM, et al. The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals[J]. Atherosclerosis, 2008, 198(2): 338-346.
[12]
Cha SH, Lee JK, Lee JY, et al. Association of CCR2 polymorphisms with the number of closed coronary artery vessels in coronary artery disease[J]. Clin Chim Acta, 2007, 382(1-2): 129-133.
[13]
Soto-Sánchez J, Santos-Juanes J, Coto-Segura P, et al. Genetic variation at the CCR5/CCR2 gene cluster and risk of psoriasis and psoriatic arthritis[J]. Cytokine, 2010, 50(2): 114-116.
[14]
Kim HS, Kim DS, Lee EY, et al. CCR2-64Iand CCR5Delta32 polymorphisms in Korean patients with myasthenia gravis[J]. J Clin Neurol, 2007, 3(3): 133-138.
[15]
Huerta C, Alvarez V, Mata IF, et al. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease[J]. Neurosci Lett, 2004, 370(2-3): 151-154.
[16]
Jordan MB, Allen CE, Weitzman S, et al. How I treat hemophagocytic lymphohistiocytosis[J]. Blood, 2011, 118(15): 4041-4052.
[17]
Trottestam H, Berglöf E, Horne A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis[J]. Acta Paediatr, 2012, 101(3): 313-318.
Onufer JJ, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments[J]. Trends Pharmacol Sci, 2002, 23(10): 459-467.
[20]
Abbadie C, Lindia JA, Cumiskey AM, et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2[J]. Proc Natl Acad Sci U S A, 2003, 100(13): 7947-7952.
